News
Whether it’s for fun or for work — we’ve all spent too much time in the sun before. However, sun exposure is the leading ...
16h
WISH-TV on MSN‘Health Spotlight’ | A new therapy for melanomaINDIANAPOLIS (WISH) — it’s a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a ...
The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...
14h
MedPage Today on MSNNovel Immunotherapy Shows Early Promise in Melanoma Resistant to PD-1 BlockadeMedian progression-free survival was 3.7 months, with 44.4% of patients being progression free at 6 months and 32.3% at 12 ...
Two groundbreaking drug discovery projects, supported by Medicines Discovery Catapult (MDC), have secured over £1m in funding ...
Skin cancer has a high cure rate, but only if caught early. Depending on the type, skin cancer can grow rapidly and become life-threatening.
A Slane man is encouraging people to get any skin changes checked, after his own experience of being diagnosed with a malignant melanoma.
WISH-TV on MSN13h
A new therapy for melanoma'Fridge cigarette' is Gen Z's new Diet Coke obsession that concerns health experts Paranormal investigator known for Annabelle doll tour dies suddenly, group says China's richest man buying water ...
Eye cancer involves uncontrolled cell growth in or around the eye, potentially leading to vision problems and other symptoms.
Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results